Luis Martinez-Sobrido, Ph.D.

Luis Martinez-Sobrido, Ph.D.

Principal Investigator
Professor - Disease Intervention & Prevention
Dr Martinez-Sobrido

Luis Martinez-Sobrido, Ph.D.

Principal Investigator
Professor - Disease Intervention & Prevention
Dr. Martinez-Sobrido’s lab is interested in the molecular biology, immunology, and pathogenesis of negative-stranded (influenza viruses, respiratory syncytial virus, human metapneumovirus, arenavirus, thogoto virus, Ebola virus, Crimean Congo hemorrhagic fever virus), positive-stranded RNA (dengue virus, Zika virus, SARS-CoV, MERS-CoV SARS-CoV-2, mouse hepatitis virus), and DNA (human cytomegalovirus, vaccinia, and monkeypox) viruses. His lab aims to develop and implement vaccines and antivirals that can be long-lasting for the treatment and control of viral infections in humans and animals.
Dr. Martinez-Sobrido is widely recognized for his expertise in generating recombinant viruses, specifically influenza, arenaviruses, SARS-CoV-2, and Zika virus, using plasmid-based reverse genetic approaches. He has also pioneered the development of techniques and screening assays to identify and characterize viral-encoded interferon antagonist proteins, establishing new molecular biology techniques to study highly pathogenic viruses without the requirement of special biosafety conditions.

Dr. Martinez-Sobrido is currently a Professor in the Disease Intervention and Prevention program at Texas Biomedical Research Institute (Texas Biomed), Adjunct Professor in the Department of Microbiology, Immunology and Molecular Genetics (MIMG) at University of Texas Health Science Center at San Antonio (UT-Health SA), and Adjunct Professor in the Department of Microbiology at University of Texas in San Antonio. Dr. Martinez-Sobrido is also Adjunct Professor at the Zheijan A&F and Yuanzhong Universities in China and at Universidad Autonoma de Yucatan, Mexico.

Dr. Martinez-Sobrido is a dedicated leader in the scientific community, serving on over 25 editorial boards across prominent journals in virology, immunology, and infectious diseases. His roles - as editorial board member, associate editor, and section editor - demonstrate both the breadth of his expertise and his commitment to advancing impactful research. His editorial service spans the following journals:

  • 2009–present – Editorial Board, Viruses

  • 2010–present – Editorial Board, Journal of Virology

  • 2012–present – Editorial Board, Virus Research

  • 2012–present – Editorial Board, ISRN Virology

  • 2012–present – Associate Editor, British Microbiology Research Journal

  • 2013–present – Editorial Board, New Journal of Science

  • 2013–present – Editorial Board, Journal of Visualized Experiments

  • 2013–present – Editorial Board, BioMed Research International

  • 2016–present – Editorial Board, Virology

  • 2017–present – Editorial Board, Vaccines

  • 2017–present – Editorial Board, Virology Section, Frontiers in Microbiology

  • 2017–present – Associate Editor, Animal Viruses Section, Viruses

  • 2019–present – Editorial Board, Pathogens

  • 2019–present – Section Editor, BioMed Research International

  • 2020–present – Associate Editor, Journal of Interferon & Cytokine Research (JICR)

  • 2020–present – Editorial Board, Antibodies

  • 2020–present – Section Editor, Virulence

  • 2021–present – Associate Editor, Emerging and Reemerging Viruses, Frontiers in Virology

  • 2021–present – Associate Editor, Frontiers in Virology

  • 2021–present – Editorial Board, Vaccine Delivery Section, Frontiers in Drug Delivery

  • 2021–present – Editorial Board, Zoonoses

  • 2022–present – Editorial Board, Frontiers in Cellular and Infection Microbiology

  • 2023–present – Associate Editor, Virology Section, Frontiers in Microbiology

  • 2024–present – Editorial Board, BMC Infectious Disease

  • 2024–present – Associate Editor, Microbes and Immunity

  • 2024–present – Editorial Board, PLOS Pathogens

  • 2025–present – Board of Reviewing Editors, PNAS Nexus